ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION (ACAID): REGULATION, BIOLOGICAL RELEVANCE, AND IMPLICATIONS FOR THERAPY
The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Immune privilege was first explored in the late 1800s by van Dooremaal, and was then extended by Medawar in the mid 1900s to fit in with emerging concepts of transplantation immunology. Modern concepts and understanding of immune privilege come from subsequent studies produced by Medawar, Billingham, and Streilein. The exploitation of the model of anterior chamber immune deviation (ACAID) in mice has allowed us to look at both cellular and molecular mechanisms involved in the prevention of potentially damaging immune responses in such privileged sites. This review gives a historical perspective of the immune privilege research and provides up-to-date information of molecules, cells, and concepts newly recognized as contributing to tolerance induction induced in such specialized areas of the body. Evidence is given to support the idea that application of such information may lead to potential for therapeutic applications of ACAID mechanisms in prevention of progression of immune-inflammatory diseases in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“subretinally delivered vectors elicit a relatively reduced immune response akin to anterior chamber-associated immune deviation (ACAID).93,94”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [94]
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
CD1 Recognition by Mouse NK1 + T Lymphocytes
Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., & Brutkiewicz, R. R. (1995) · Science · doi:10.1126/science.7538697 · Cited by 914
Weiner, H. L. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.809 · Cited by 906
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
Porcelli, S., Yockey, C. E., Brenner, M. B., & Balk, S. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.1 · Cited by 756
Oral tolerance: immune mechanisms and treatment of autoimmune diseases
Weiner, H. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01053-0 · Cited by 731
Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view
Cserr, H. F., & Knopf, P. M. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90027-5 · Cited by 653
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., et al. (1998) · Nature · doi:10.1038/34419 · Cited by 646
Research works printed but not linked: 44
- van Dooremaal J.C., 1873, Akbrecg. Vab. Graefes Arch. Opthalomol., 19, 358
- P.B., 1945, London, 79, 157
- P.B., 1948, Pathol., 29, 58
- Streilein J.W., 1979, Masson et Cie, 174
- Asherson G.L., 1965, Immunology, 9, 205
- Niederkorn J., 1980, Invest. Opthalmol. Vis. Sci., 20, 355
- Whittum J.A., 1984, Invest. Opthalmol. Vis. Sci., 25, 1065
- McLeish W., 1989, Regional Immunol., 2, 236
- Niederkorn J.Y., 1990, Adv. Immunol., 48, 1999
- Mizuno K., 1989, Invest. Ophthalmol. Vis. Sci., 30, 1112
- Streilein J.W., 2001, Invest. Ophthalmol. Vis. Sci., 42, S523
- Jiang L.Q., 1991, Invest. Ophthalmol. Vis. Sci., 32, 224
- Jiang L.Q., 1993, Invest. Opthahalmol. Vis. Sci., 34, 3347
- Eichorn M., 1993, Invest. Ophthalmol. Vis. Sci., 34, 2926
- Kaiser C.J., 1985, Regional Immunol., 2, 42
- Taylor A.W., 1998, Invest. Opthahalmol. Vis. Sci., 39, 1372
- Miyamoto K.I., 1999, Invest. Ophthalmol. Vis. Sci., 40, S986
- Takeuchi M., 1999, Immunol., 98576
- Goslings R.O., 1998, Invest. Ophthalmol. Vis. Sci., 39, 989
- Cousins S.W., 1991, Invest. Ophthalmol. Vis. Sci., 32, 2201
- Biros D.J., 2001, Invest. Ophthalmol. Vis. Sci., 42, S929
- Knisely T.L., 1994, Invest. Opthalmol. Vis. Sci., 35, 3711
- Williamson S.P., 1989, Immunology, 67, 96
- H., 1989, The Journal of Immunology, 153, 1982
- Kezuka T., 2000, Immunology, 41, 1410
- Yao Y.F., 1997, Invest. Ophthalmol. Vis. Sci., 38, 534
- Kezuka T., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1803
- Kezuka T., 2000, Invest. Ophthalmol. Vis. Sci., 41, 1410
- Waldrep J.C., 1984, Invest. Opthalmol. Vis. Sci., 25, 447
- Wilbanks G., 1990, Immunology, 71, 383
- Martin F., 2000, Immunol. Rev., 175, 70, 10.1111/j.1600-065X.2000.imr017515.x · doi:10.1111/j.1600-065x.2000.imr017515.x · Paper page
- Sonoda K.-H., 2001, Invest. Opthalmol. Vis. Sci., 42, S930
- Sonoda K.-H., 2001, Stein-Streilein. J. Immunol., 166, 42
- Faunce D.E., 2001, Invest. Opthalmol. Vis. Sci., 42, S930
- T., 1999, Cancer Res., 59, 5102
- Parker D.C., 1992, FASEB J., 131, 2777
- Wilbanks G.A., 1989, Regional Immunol., 2, 390
- Wilbanks G.A., 1990, Immunology, 71, 383
- 10.1146/annurev.iy.12.040194.004113 · doi:10.1146/annurev.iy.12.040194.004113 · Paper page
- Mosmann T.R., 1992, Sci., 664, 89
- Wilbanks G.A., 1990, Immunology, 71, 566
- Atherton S.S., 1987, Invest. Opthamol. Vis. Sci., 28, 859
- Rouse M.G., 1992, J. Immunol., 142, 3035
- Niederkorn J.Y., 1996, Invest. Ophthalmol. Vis. Sci., 37, 2700
Cited by
Items 101–200 of 218
Collins, K. H., Herzog, W., Reimer, R. A., Reno, C. R., Heard, B. J., & Hart, D. A. (2017) · Inflammation Research · doi:10.1007/s00011-017-1102-y · Cited by 20
CENTRAL TOLERANCE MECHANISMS IN CONTROL OF SUSCEPTIBILITY TO AUTOIMMUNE UVEITIC DISEASE
Gery, I., & Egwuagu, C. (2002) · International Reviews of Immunology · doi:10.1080/08830180212061 · Cited by 18
Stem Cells: Immunology and Immunomodulation
Tena, A., & Sachs, D. H. (2014) · Developments in ophthalmology · doi:10.1159/000357360 · Cited by 19
Denniston, A. K., Tomlins, P. J., Williams, G. P., Kottoor, S. H., Khan, I. J., Oswal, K. S., Salmon, M., Wallace, G. R., Rauz, S., Murray, P. I., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8802 · Cited by 21
Vendomèle, J., Dehmani, S., Khebizi, Q., Galy, A., & Fisson, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00504 · Cited by 18
Wessely corneal ring phenomenon: An unsolved pathophysiological dilemma
Ruiz‐Lozano, R. E., Salan‐Gomez, M., Rodríguez-García, A., Quiroga-Garza, M. E., Ramos‐Dávila, E. M., Perez, V. L., Azar, N. S., Merayo-Llovés, J., Hernández‐Camarena, J. C., & Valdez-García, J. E. (2023) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2023.02.009 · Cited by 17
Gene Therapy in Corneal Transplantation
Qazi, Y., & Hamrah, P. (2013) · Seminars in Ophthalmology · doi:10.3109/08820538.2013.825297 · Cited by 20
Blood–Retinal Barrier, Immune Privilege, and Autoimmunity
Katamay, R., & Nussenblatt, R. B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00027-8 · Cited by 23
Lü, B., Lin, Y., Tsai, Y.-C., Girman, S., Adamus, G., Jones, M. K., Shelley, B., Svendsen, C. N., & Wang, S. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.1.7 · Cited by 16
“immunosuppressive factors, and activation of some immunoregulatory T cells.(29,53) This property of immune privilege in the eye is beneficial for cell transplantation.”
BackgroundAnterior Chamber-Associated Immune Deviation
Biros, D. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2007.12.006 · Cited by 17
Liu, P., Thomson, B. R., Khalatyan, N., Feng, L., Liu, X., Savas, J. N., Quaggin, S. E., & Jin, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807982115 · Cited by 17
“These selective barriers prevent certain plasma proteins from entering the eye, an essential function to maintain ocular immune privilege (4, 5).”
BackgroundBernal‐Alferes, B., Gómez-Mosqueira, R., Ortega-Tapia, G. T., Burgos‐Vargas, R., García-Latorre, E., Domínguez‐López, M. L., & Romero‐López, J. P. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad046 · Cited by 18
Schöllhorn, L., Bock, F., & Cursiefen, C. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0020 · Cited by 18
“102,103 While specialized CD4 + T cells suppress the initial activation and differentiation of naive T cells into T H1 effector cells, CD8 + T cells inhibit the expression of T H1 -mediated immunity, such as alloantigen-specific delayed-type hypersensitivity, 104 and promote long-term survival.”
The Influence of Rejection Episodes in Recipients of Bilateral Corneal Grafts
Williams, K. A., Kelly, T., Lowe, M. T., & Coster, D. J. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.03002.x · Cited by 16
“The phenomenon of anterior chamber-associated immune deviation, in which introduction of foreign antigen into the anterior chamber of experimental animals results in a systemic depression of the delayed type hypersensitivity response to that antigen (17), is further evidence of an interaction (albeit immunomodulatory)…”
BackgroundOral tolerance: lessons on treatment of food allergy
Ko, J., & Mayer, L. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200512000-00006 · Cited by 16
Jiang, L., He, H., Yang, P., Lin, X., Zhou, H., Huang, X., & Kijlstra, A. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0947-8 · Cited by 16
“immunosuppressive microenvironment and endows APC with ACAID-inducing capability [8, 12, 26], Kezuka et al.”
BackgroundNakamura, T., Terajewicz, A., & Stein‐Streilein, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2643 · Cited by 17
Self-citationMilikan, J. C. M., Kuijpers, R. W. A. M., Baarsma, G. S., Osterhaus, A. D. M. E., & Verjans, G. M. G. M. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.11.008 · Cited by 15
Jiang, L., Yang, P., He, H., Li, B., Lin, X., Hou, S., Zhou, H., Huang, X., & Kijlstra, A. (2007) · PubMed Central · Cited by 15
Burlingham, W. J., & Goulmy, E. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.289 · Cited by 14
Mechanisms Underlying Autoimmune Uveitis
Caspi, R. R. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.05.006 · Cited by 14
Cross Talk among Cells Promoting Anterior Chamber-Associated Immune Deviation
Stein‐Streilein, J., & Watte, C. M. (2007) · KARGER eBooks · doi:10.1159/000099262 · Cited by 15
Self-citationThe anterior chamber of the eye technology and its anatomical, optical, and immunological bases
Yang, S.-N., Shi, Y., & Berggren, P. (2024) · Physiological Reviews · doi:10.1152/physrev.00024.2023 · Cited by 14
Фисенко, Н. В., Trufanov, S. V., Avetisov, K. S., Vtorushina, V. V., & Суббот, А. М. (2021) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202113703113 · Cited by 13
Immune mechanisms of intraocular inflammation
Schewitz‐Bowers, L. P., Lee, R., & Dick, A. D. (2010) · Expert Review of Ophthalmology · doi:10.1586/eop.09.68 · Cited by 14
Agrawal, K., Hong, A. S. Y., Cifuentes‐González, C., Kumar, V. S., Rojas-Carabali, W. A., Zhang, S., Wang, Q., de‐la‐Torre, A., Gijs, M., Gill, T., et al. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101409 · Cited by 15
Generation of Regulatory T Cells to Antigen Expressed in the Retina
McPherson, S. W., Heuss, N. D., Lehmann, U., & Gregerson, D. S. (2011) · Current Immunology Reviews · doi:10.2174/157339511796196584 · Cited by 14
“The down regulation of immune responses to Ags placed in the anterior chamber of the eye (anterior chamber associated immune deviation, ACAID) is mediated by both CD4+ and CD8+ Tregs [32, 33].”
BackgroundYousef, Y. A., Strzalkowska, A., Hillenkamp, J., Rosentreter, A., & Loewen, N. A. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-04933-z · Cited by 14
Upregulation of CD94 on CD8+T Cells in Anterior Chamber-Associated Immune Deviation
He, H., Yang, P., Jiang, L., Zhang, J., Zhao, C., Chen, L., Lin, X., Zhou, H., & Kijlstra, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-53 · Cited by 15
“It is characterized by an antigen-specific suppression of the delayed-type hypersensitivity (DTH) response and a shift in antibody production away from complement-fixing isotypes[1,2].”
BackgroundWilcock, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-072160561-6.50007-1 · Cited by 12
Tao, T., Liu, Y., Zhang, J., Huang, L., & Tao, Y. (2022) · Ophthalmic Research · doi:10.1159/000524485 · Cited by 13
The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests
Inagaki, E., Arai, E., Hatou, S., Sayano, T., Taniguchi, H., Negishi, K., Kanai, Y., Sato, Y., Okano, H., Tsubota, K., et al. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac036 · Cited by 12
The role of lymphatic vessels in corneal fluid homeostasis and wound healing
Hadrian, K., & Cursiefen, C. (2024) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-023-00381-y · Cited by 11
“This mechanism effectively suppresses antigen-specific, delayed-type hypersensitivity reactions [20].”
BackgroundNanotherapy for Neural Retinal Regeneration
Yu, C., Dong, L., Lv, Y., Shi, X., Zhang, R., Zhou, W., Wu, H., Li, H., Li, Y., Zhou, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202409854 · Cited by 13
Heřmánková, B., Javorková, E., Palacká, K., & Holáň, V. (2025) · Cell Transplantation · doi:10.1177/09636897241312798 · Cited by 11
Evidence for Extrathymic Generation of Regulatory T Cells Specific for a Retinal Antigen
Gregerson, D. S., Heuss, N. D., Lehmann, U., & McPherson, S. W. (2008) · Ophthalmic Research · doi:10.1159/000119868 · Cited by 9
Intravitreal panitumumab and myopic macular degeneration
Bikbov, M. M., Kazakbaeva, G. M., Holz, F. G., Panda‐Jonas, S., Gilemzianova, L. I., Khakimov, D. A., & Jonas, J. B. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-323383 · Cited by 8
Holáň, V., Vı́tová, A., Pindjáková, J., Krulová, M., Zajı́cová, A., & Filipec, M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02457.x · Cited by 8
* Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis
Nussenblatt, R. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0667-3.00006-0 · Cited by 11
Ikeda, T., Nakamura, K., Oku, H., Morishita, S., Fukumoto, M., Suzuki, H., Kida, T., Horie, T., Sugiyama, T., & Takai, S. (2015) · Clinical ophthalmology · doi:10.2147/opth.s82015 · Cited by 7
Hypothesis of immune privilege of the cornea and pathophysiology of graft rejection
Trufanov, S. V., Суббот, А. М., Malozhen, S. A., & Krakhmaleva, D. A. (2016) · Russian Annals of Ophthalmology · doi:10.17116/oftalma20161325117-124 · Cited by 9
Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation
Tsukahara, R., Takeuchi, M., Akiba, H., Kezuka, T., Takeda, K., Usui, Y., Usui, M., Yagita∥, H., & Okumura, K. (2005) · International Immunology · doi:10.1093/intimm/dxh234 · Cited by 9
Reprogramming the Immune System Using Antibodies
Graça, L., & Waldmann, H. (2006) · Humana Press eBooks · doi:10.1385/1-59745-049-9:247 · Cited by 7
Vendomèle, J., Chauveau, G. A., Dalkara, D., Galy, A., & Fisson, S. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.191 · Cited by 6
“22,23 Moreover, some years ago, our team described a similar mechanism occurring in the subretinal space that we named subretinal-associated immune inhibition (SRAII).”
Spelta, S., Micera, A., Gaudenzi, D., Niutta, M., Surico, P. L., Vincentis, A. D., Coassin, M., & Zazzo, A. D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123431 · Cited by 6
“In the cornea and anterior chamber, several active mechanisms of immune tolerance contribute to a high success rate of transplantation [4–6].”
BackgroundIkeda, T., Nakaizumi, A., Fukumoto, M., Kida, T., Suzuki, H., Morishita, S., Satou, T., Oku, H., & Nakamura, K. (2015) · Clinical ophthalmology · doi:10.2147/opth.s75422 · Cited by 8
Akinfenwa, P. Y., Bond, W. S., Ildefonso, C. J., Hurwitz, M. Y., & Hurwitz, R. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773549 · Cited by 6
“The immune privilege associated with the eye, anterior chamber-associated immune deviation, protects the intraocular structures and limits the systemic immune response to the proteins produced by the transgenes and to the viral vectors themselves (16, 17).”
BackgroundLee, J.-Y., Sohn, H., Kim, C., Kim, T., & Lee, H. S. (2022) · Biomedicines · doi:10.3390/biomedicines10123223 · Cited by 6
“In a healthy cornea, the immune privilege of the eye suppresses antigen-specific delayed-type hypersensitivity [38] mediated by anterior chamber-associated immune deviation [38,39].”
BackgroundCone, R. E., Chattopadhyay, S., Pais, R., Bhowmick, S., Sharafieh, R., Lemire, Y., & O’Rourke, J. (2010) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s6113 · Cited by 6
A Privileged View of NKT Cells and Peripheral Tolerance Through the Eye
Stein‐Streilein, J. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940490912371 · Cited by 6
Self-citationEndothelial failure and rejection in recipients of corneas from the same donor
Downward, L., Ahmed, M., Hopkinson, C. L., Romano, V., Curnow, E., & Kaye, S. B. (2022) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2021-000965 · Cited by 5
Folliculogenesis following syngeneic transplantation of young murine ovaries into the testes
Sato, M., Sakurai, T., Kiryu, K., TAKEDA, M., & Yasuoka, Y. (2006) · Reproductive Medicine and Biology · doi:10.1111/j.1447-0578.2006.00126.x · Cited by 5
Intracameral Microimaging of Maturation of Human iPSC Derivatives into Islet Endocrine Cells
Zhao, K., Shi, Y., Yu, J., Yu, L., Mael, A. A., Li, Y., Kolton, A., Joyce, T., Odorico, J., Berggren, P., et al. (2022) · Cell Transplantation · doi:10.1177/09636897211066508 · Cited by 4
Hart, D. A. (2018) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2018.113004 · Cited by 6
“This compartment was chosen as the interior of the eye is an immune privileged site [29-32], and alterations to this site could lead to subsequent alterations at the level of the retina.”
BackgroundPersistent Expression of PEDF in the Eye Using High-capacity Adenovectors
Chen, P., Hamilton, M. M., Thomas, C. A., Kroeger, K. M., Carrion, M. E., MacGill, R. S., Gehlbach, P. L., Brough, D. E., Wei, L. L., King, C. R., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.211 · Cited by 6
Sustained Anti-Staphylococcal Effect of Lysostaphin in the Rabbit Aqueous Humor
Balzli, C. L., McCormick, C. C., Caballero, A. R., & O’Callaghan, R. J. (2010) · Current Eye Research · doi:10.3109/02713681003664949 · Cited by 5
The role of CXC and CC chemokines in patients with uveal melanoma
Myakoshina, E. B., Kulikova, I. G., Balatskaya, N. V., Катаргина, Л. А., & Saakyan, S. V. (2021) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202113704131 · Cited by 4
Infections Associated with Retinal Autoimmunity
Hooks, J. J., Detrick, B., & Nussenblatt, R. B. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50054-5 · Cited by 4
Igarashi, A., Shimizu, T., Takeda, M., Ida, Y., Ishida, A., Yuda, K., Yuda, K., Wajima, H., Kobayashi, A., Nakashizuka, H., et al. (2023) · Cornea · doi:10.1097/ico.0000000000003335 · Cited by 4
Infections Associated with Retinal Autoimmunity
Detrick, B., Hooks, J. J., & Nussenblatt, R. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63269-2.00059-3 · Cited by 4
“It is known that an antigen placed into the anterior chamber of the eye induces a deviated immune response, with a marked decrease in cell-mediated responses, but intact cytotoxic and B-cell responses are maintained (1) .”
BackgroundMartínez, M. D. C. J., Mejía, H., Linares, M., Santacruz, C., Sánchez-Navarro, A., Suárez, R., & Garfias, Y. (2006) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912006000700007 · Cited by 4
“Culture SN was used to determine TGF-β via a quantitative ELISA sandwich following the methodology suggested by the manufacturer (R&D Systems, MN, USA).”
BackgroundInfluentialForrester, J. V., & Cornall, R. J. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01774.x · Cited by 4
Ren, Y., Yang, P., Li, B., Gao, Y., Zhou, H., Huang, X., Zhu, L., & Kijlstra, A. (2006) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0255-0 · Cited by 4
“ACAID is characterized by a deficiency in delayed-type hypersensitivity (DTH) responses and decreased expression of IgG isotypes [24, 28].”
BackgroundLatanoprost does not affect immune privilege of corneal allografts
Wang, M., Kitahara, Y., Yoshida, A., & Hori, J. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.11.012 · Cited by 4
Liquid Biopsy for Uveal Melanoma. Does It Make Sense?
Ovanesyan, V. E., Лихванцева, В. Г., Рычкова, С. И., & Selkov, S. А. (2022) · Ophthalmology in Russia · doi:10.18008/1816-5095-2022-3-594-602 · Cited by 3
Li, Q., Pu, L., Cheng, S., Tang, S., Zhang, J., & Qing, G. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.8.51 · Cited by 3
Corneal stromal cells selectively inhibit the production of certain anti-inflammatory cytokines
Holáň, V. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.1.101 · Cited by 3
Macrophage Migration Inhibitory Factor (MIF) is a Key Player in Dry Eye Disease
Rivera, L. A., Hernández, P. E., Vannan, D. T., Reyes, J. L., Rodríguez, T., Sánchez-Barrera, C. Á., González, M. I., Bustos‐Arriaga, J., Ramos, O. A., Juárez, I., et al. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2023.2290624 · Cited by 3
“28 Currently, it is well known that the spleen is central as a niche of immune modulation both for maintaining eye homeostasis as well as for induction of pathogenic responses and this is achieved by immune cells through re-circulating between spleen and eye.”
Chowdhury, P., & Borah, J. M. (2012) · InTech eBooks · doi:10.5772/48380 · Cited by 2
How Ocular Surface Disorder Affected Corneal Graft Survival
Siregar, S. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98480 · Cited by 2
Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis
Sen, H. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-48014-7.00001-4 · Cited by 3
Kulikova, I. G., Слепова, О. С., Denisova, E. V., Kovaleva, L. A., Макаров, П. В., & Lovpache, D. N. (2015) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2015-2-179-182 · Cited by 2
“Прежде всего это относится к ACAID (anterior chamber associated immune deviation) – иммунному отклонению, которое проявляется при попадании растворимых антигенов в переднюю камеру глаз [4, 8].”
Impact of glaucoma surgery on recurrence rate in cytomegalovirus anterior uveitis
Park, M. H., Ahn, Y. S., Jeon, S. J., Kim, S. E., Lim, S. J., Lee, J. Y., Choi, J. A., & Kim, M. H. (2025) · British Journal of Ophthalmology · doi:10.1136/bjo-2025-327446 · Cited by 1
Ren, D., Chauveau, G. A., Cabon, E., Vendomèle, J., Vignal‐Clermont, C., Saliba, H., Ail, D., Dalkara, D., & Fisson, S. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101443 · Cited by 1
Immune Profiling of Uveal Melanoma Liver Metastases and Response to Checkpoint Inhibitors
Shao, Y. F., Baca, Y., Hinton, A. C., Xiu, J., Vanderwalde, A. M., Hadfield, M. J., Park, S. J., Darabi, S., Sato, T., & Moser, J. C. (2025) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000558 · Cited by 1
“24 In the background of this, primary UMs are considered immune-silent with low PD-L1 expression, low TMB, and overall low leukocyte in fi ltrate fraction.”
Liu, A. S., Ildefonso, C. J., Bond, W. S., Hurwitz, M. Y., & Hurwitz, R. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236175 · Cited by 1
“The mechanism of anterior chamber acquired immune deviance (ACAID) can explain the long duration of transgene expression of cells within the ocular environment [29, 30].”
BackgroundRole of Complement in Ocular Immune Response
Jha, P., Bora, P. S., & Bora, N. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374203-2.00004-x · Cited by 1
Characterization of Dendritic Cells and other Antigen‐presenting Cells in the Eye
Stein‐Streilein, J. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch6
Self-citationRegulation of Immune Responses
Dana, R., & Foster, C. S. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50013-8 · Cited by 1
Hara, K., Kameya, S., & Yamaki, K. (2004) · Institutional Repositories DataBase (IRDB) · Cited by 1
Esfandiari, H., Taubenslag, K. J., Shah, P., Goyal, S., Weiner, A. J., Severson, M. L., Weiner, A., Grove, D. S., Bussel, I. I., & Loewen, N. A. (2018) · Preprints.org · doi:10.20944/preprints201811.0109.v1 · Cited by 1
A molecular approach to the community ecology of parasites of freshwater fish
Locke, S. A. (2010) · Spectrum Research Repository (Concordia University) · Cited by 1
Orally induced tolerance towards nickel
Roelofs-Haarhuis, H. M. (2005) · Radboud Repository (Radboud University)
Levy-Clarke, G. A., Li, Z., Kump, L. I., & Nussenblatt, R. B. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50052-4
Recent Developments in Herpes Stromal Keratitis
Frank, G. M., & Hendricks, R. L. (2006) · Springer eBooks · doi:10.1007/978-3-540-30798-3_6
The End of an Era: Wayne Streilein and His Impact on Transplantation Immunology
Burlingham, W. J. (2004) · Transplantation · doi:10.1097/01.tp.0000135954.48021.6f
Antón, J. C. R. (1988) · Dialnet (Universidad de la Rioja)
Analysis of tolerance in human and nonhuman primates using delayed-type hypersensitivity
Jankowska−Gan, E., & Burlingham, W. J. (2004) · Current Opinion in Organ Transplantation · doi:10.1097/01.mot.0000130145.14353.e5
Identifying molecular targets for cancer therapy
Culp, W. D. (2007) · Figshare
Immunosuppression with mycophenolate mofetil after penetrating keratoplasty: our clinical experience
Hurtado‐Sarrió, M., Duch-Samper, A. M., Cisneros-Lanuza, Á., Santos‐Arteaga, F. J., Menezo, J. L., & Díaz-Llopis, M. (2010) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Pathogenesis of Infection and the Ocular Immune Response
(2007) · CRC Press eBooks · doi:10.3109/9781420020434-2
Surgical Management of Macular Edema Associated with Uveitis
Grigalunas, A. L., & Merrill, P. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-39766-5_9
CD8+ T Regulatory Cells in Eye Derive Tolerance
Stein‐Streilein, J., & Keino, H. (2008) · Springer eBooks · doi:10.1007/978-0-387-77909-6_25
“The posterior surfaces of the iris, the ciliary body, and neural retina are lined with pigment epithelium (PE) that partially surrounds the privileged sites [12] of the anterior chamber [62], the vitreous cavity [63], and the subretinal space [64,65] respectively.”
BackgroundSelf-citationOther Ocular Disorders and the Immune Response
Nussenblatt, R. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0667-3.00036-9
Privilège immunologique de l'œil
de Kozak, Y., Camelo, S., Lajavardi, L., & Béhar‐Cohen, F. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-71107-7.50003-2
Sönmez, R. E., İlhan, M., & Ertekın, C. (2019) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.04.064
The role of immune regulatory cells in sight-threatening non-infectious uveitis
Zhang, X. (2019) · UCL Discovery (University College London)
Maternal recognition of pregnancy in some domestic animals: A review
(2019) · Savannah Veterinary Journal · doi:10.36759/svj.2017.003
Vanathi, M., Shukla, R., Balakrishnan, P., Dwivedi, R., Gupta, N., & Tandon, R. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_552_19
“The anterior chamber‐associated immune deviation (ACAID) is of significant importance as a system of alloantigen‐specific peripheral immune tolerance to antigens in the anterior chamber, which is capable of altering the systemic cytotoxic immune response.[11] ACAID promotes corneal graft survival by way of effecting t…”
Background
Metadata
- Authors
- STEIN-STREILEIN, J., & STREILEIN, J. W.
- Affiliations
- Harvard University (US)
- Venue
- International Reviews of Immunology
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 21
- Issue
- 2-3
- Pages
- 123-152
- ISSN
- 0883-0185 (ISSN-L)
- 1563-5244
- OpenAlex
- W1966161103
- Cited by
- 218
- References
- 132
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 7 · 2012: 11
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Reviews of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- anterior chamber-associated immune deviation, immune privilege, tolerance induction, ocular immunology, transplantation immunology
- MeSH terms
- Animals, Anterior Chamber, Antigen-Presenting Cells, Eye Diseases, Graft vs Host Disease, Humans, Immune Tolerance, Killer Cells, Natural, Ovalbumin, T-Lymphocytes, Transplantation Immunology, Th1 Cells, Th2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.